Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 22, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) resulting from movements in various employee benefit plans and trusts.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details within employee benefit schemes. Specific transaction data includes:
- US Retirement Savings Plan: ADR holdings fluctuated between 18,810,445 and 18,904,402 shares with average transaction prices of $44.51 and $43.59.
- SmithKline Beecham Employee Benefit Trust: Involved the sale and transfer of small quantities of Ordinary Shares (ranging from 522 to 1,917 shares) related to the Annual Investment Plan and Bonus Investment Plan.
- GSK Employee Trust: Transferred 6,161 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Material Changes
There are no material changes to the company's financial position or operations reported in this filing. The changes noted are strictly administrative movements within discretionary employee funds and trusts, affecting the potential beneficial interests of directors Dr. J P Garnier, Dr. T Yamada, and Mr. John Coombe.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a compliance report regarding director share interests and does not contain forward-looking statements or risk assessments.
Key Facts for Investor Verification
- Verify the total aggregate holdings of directors Dr. J P Garnier, Dr. T Yamada, and Mr. John Coombe across all employee benefit plans.
- Confirm the impact of the reported ADR price fluctuations ($43.59 - $44.51) on the valuation of the US Retirement Savings Plan.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 regarding the 6,161 shares transferred.
- Note that this filing contains no operational or financial performance data for the period.